March 11, 2024
Phase 3 CELLEBRATE trial testing regenerative stem cell-based therapy to improve urinary control for women
The Phase 3 CELLEBRATE trial to test a regenerative stem cell-based therapy in treating patients with stress urinary incontinence is continuing to recruit additional subjects after changing its study protocol to include only patients who have already tried surgery.
By Craig Boerner